Optimizing the dose of hydroxyurea therapy for patients with β-thalassemia intermedia (Hb E-β-thalassemia): a single center study from eastern India. (opent nieuw venster)

Bohara VV, Ray S, Chakrabarti P, Ray SS, Nath UK, Chaudhuri U.

Bron‎: Hemoglobin 2014;38(1):44-8.

Geïndexeerd‎: PubMed 24144212

DOI‎: 10.3109/03630269.2013.845844

https://www.ncbi.nlm.nih.gov/pubmed/24144212 (opent nieuw venster)

Hydroxyurea in thalassemia intermedia--a promising therapy. (opent nieuw venster)

Dixit A, Chatterjee TC, Mishra P, Choudhry DR, Mahapatra M, Tyagi S, Kabra M, Saxena R, Choudhry VP.

Bron‎: Ann Hematol 2005;84(7):441-6.

Geïndexeerd‎: PubMed 15838670

DOI‎: 10.1007/s00277-005-1026-4

https://www.ncbi.nlm.nih.gov/pubmed/15838670 (opent nieuw venster)

Effect of hydroxyurea on the transfusion requirements in patients with severe HbE-beta-thalassaemia: a genotypic and phenotypic study. (opent nieuw venster)

Italia KY, Jijina FF, Merchant R, Panjwani S, Nadkarni AH, Sawant PM, Nair SB, Ghosh K, Colah RB.

Bron‎: J Clin Pathol 2010;63(2):147-50.

Geïndexeerd‎: PubMed 20154037

DOI‎: 10.1136/jcp.2009.070391

https://www.ncbi.nlm.nih.gov/pubmed/20154037 (opent nieuw venster)

Echocardiographic finding in beta-thalassemia intermedia and major: absence of pulmonary hypertension following hydroxyurea treatment in beta-thalassemia intermedia. (opent nieuw venster)

Karimi M, Borzouee M, Mehrabani A, Cohan N.

Bron‎: Eur J Haematol 2009;82(3):213-8.

Geïndexeerd‎: PubMed 19077048

DOI‎: 10.1111/j.1600-0609.2008.01192.x

https://www.ncbi.nlm.nih.gov/pubmed/19077048 (opent nieuw venster)

Effect of combination therapy of hydroxyurea with l-carnitine and magnesium chloride on hematologic parameters and cardiac function of patients with beta-thalassemia intermedia. (opent nieuw venster)

Karimi M, Mohammadi F, Behmanesh F, Samani SM, Borzouee M, Amoozgar H, Haghpanah S.

Bron‎: Eur J Haematol 2010;84(1):52-8.

Geïndexeerd‎: PubMed 19799627

DOI‎: 10.1111/j.1600-0609.2009.01356.x

https://www.ncbi.nlm.nih.gov/pubmed/19799627 (opent nieuw venster)

Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece. (opent nieuw venster)

Loukopoulos D, Voskaridou E, Kalotychou V, Schina M, Loutradi A, Theodoropoulos I.

Bron‎: Blood Cells Mol Dis 2000;26(5):453-66.

Geïndexeerd‎: PubMed 11112383

DOI‎: 10.1006/bcmd.2000.0328

https://www.ncbi.nlm.nih.gov/pubmed/11112383 (opent nieuw venster)

Fetal globin stimulant therapies in the beta-hemoglobinopathies: principles and current potential. (opent nieuw venster)

Perrine SP.

Bron‎: Pediatr Ann 2008;37(5):339-46.

Geïndexeerd‎: PubMed 18543545

https://www.ncbi.nlm.nih.gov/pubmed/18543545 (opent nieuw venster)

Single and combination drug therapy for fetal hemoglobin augmentation in hemoglobin E-beta 0-thalassemia: Considerations for treatment. (opent nieuw venster)

Singer ST, Kuypers FA, Olivieri NF, Weatherall DJ, Mignacca R, Coates TD, Davies S, Sweeters N, Vichinsky EP.

Bron‎: Ann N Y Acad Sci 2005;1054:250-6.

Geïndexeerd‎: PubMed 16339672

DOI‎: 10.1196/annals.1345.031

https://www.ncbi.nlm.nih.gov/pubmed/16339672 (opent nieuw venster)

Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules. (opent nieuw venster)

Chaidos A, Makis A, Hatzimichael E, Tsiara S, Gouva M, Tzouvara E, Bourantas KL.

Bron‎: Acta Haematol 2004;111(4):189-95.

Geïndexeerd‎: PubMed 15153710

DOI‎: 10.1159/000077551

https://www.ncbi.nlm.nih.gov/pubmed/15153710 (opent nieuw venster)

Efficacy of erythropoietin on dialysis in patients with beta thalassemia minor. (opent nieuw venster)

Di Iorio B, De Nicola L, Bellizzi V, Minutolo R, Zamboli P, Rubino R, Fuiano G, Conte G.

Bron‎: Blood Purif 2004;22(5):453-60.

Geïndexeerd‎: PubMed 15359104

DOI‎: 10.1159/000080729

https://www.ncbi.nlm.nih.gov/pubmed/15359104 (opent nieuw venster)

The role of recombinant human erythropoietin in the treatment of thalassemia. (opent nieuw venster)

Rachmilewitz EA, Aker M.

Bron‎: Ann N Y Acad Sci 1998;850:129-38.

Geïndexeerd‎: PubMed 9668535

https://www.ncbi.nlm.nih.gov/pubmed/9668535 (opent nieuw venster)

Darbepoetin alfa for the treatment of anaemia in alpha- or beta- thalassaemia intermedia syndromes. (opent nieuw venster)

Singer ST, Vichinsky EP, Sweeters N, Rachmilewitz E.

Bron‎: Br J Haematol 2011;154(2):281-4.

Geïndexeerd‎: PubMed 21496003

DOI‎: 10.1111/j.1365-2141.2011.08617.x

https://www.ncbi.nlm.nih.gov/pubmed/21496003 (opent nieuw venster)

The emerging role of fetal hemoglobin induction in non-transfusion-dependent thalassemia. (opent nieuw venster)

Thein SL.

Bron‎: Blood Rev 2012;26 Suppl 1:S35-9.

Geïndexeerd‎: PubMed 22631042

DOI‎: 10.1016/S0268-960X(12)70011-5

https://www.ncbi.nlm.nih.gov/pubmed/22631042 (opent nieuw venster)